C. Wiebe, I. W. Gibson, T. D. Blydt-hansen, M. Karpinski, J. Ho et al., Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.12, issue.5, pp.1157-67, 2012.

C. Lefaucheur, A. Loupy, G. S. Hill, J. Andrade, D. Nochy et al., Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation, J Am Soc Nephrol JASN, vol.21, issue.8, pp.1398-406, 2010.

M. R. Morrell, J. M. Pilewski, C. J. Gries, M. R. Pipeling, M. M. Crespo et al., De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, vol.33, issue.12, pp.1288-94, 2014.

H. Kaneku, J. G. O'leary, N. Banuelos, L. W. Jennings, B. M. Susskind et al., De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.13, issue.6, pp.1541-1549, 2013.

J. D. Smith, N. R. Banner, I. M. Hamour, M. Ozawa, A. Goh et al., De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.11, issue.2, pp.312-321, 2011.

R. Pei, J. Lee, N. Shih, M. Chen, and P. I. Terasaki, Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities, Transplantation, vol.75, issue.1, pp.43-52, 2003.

M. Schnaidt, C. Weinstock, M. Jurisic, B. Schmid-horch, E. A. Wernet et al., HLA antibody specification using single-antigen beads--a technical solution for the prozone effect, Transplantation, vol.92, issue.5, pp.510-515, 2011.

J. Visentin, M. Vigata, S. Daburon, C. Contin-bordes, V. Fremeaux-bacchi et al., Deciphering complement interference in anti-human leukocyte antigen antibody detection with flow beads assays, Transplantation, vol.98, issue.6, pp.625-656, 2014.

G. Guidicelli, J. Visentin, N. Franchini, C. Borg, P. Merville et al., Prevalence, distribution and amplitude of the complement interference phenomenon in single antigen flow beads assays. HLA, vol.91, pp.507-520, 2018.

M. J. Everly, J. J. Everly, L. J. Arend, P. Brailey, B. Susskind et al., Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.9, issue.5, pp.1063-71, 2009.

D. Viglietti, A. Loupy, A. O. Bestard, O. Van-huyen, J. Taupin et al., Dynamic Prognostic Score to Predict Kidney Allograft Survival in Patients with Antibody-Mediated Rejection, J Am Soc Nephrol JASN, vol.29, issue.2, pp.606-625, 2018.

P. Archdeacon, M. Chan, C. Neuland, E. Velidedeoglu, J. Meyer et al., Summary of FDA antibody-mediated rejection workshop, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.11, issue.5, pp.896-906, 2011.

S. S. Wan, T. D. Ying, K. Wyburn, D. M. Roberts, M. Wyld et al., The Treatment of Antibody-Mediated Rejection in Kidney Transplantation: An Updated Systematic Review and Meta-Analysis, Transplantation, vol.102, issue.4, pp.557-68, 2018.

C. Lefaucheur, D. Nochy, J. Andrade, J. Verine, C. Gautreau et al., Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.9, issue.5, pp.1099-107, 2009.

P. N. Rocha, D. W. Butterly, A. Greenberg, D. N. Reddan, J. Tuttle-newhall et al., Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection, Transplantation, vol.75, issue.9, pp.1490-1495, 2003.

R. W. Lehrich, P. N. Rocha, N. Reinsmoen, A. Greenberg, D. W. Butterly et al., Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation, Hum Immunol, vol.66, issue.4, pp.350-358, 2005.

G. A. Böhmig, M. Wahrmann, H. Regele, M. Exner, B. Robl et al., Immunoadsorption in severe C4d-positive acute kidney allograft rejection: a randomized controlled trial, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.7, issue.1, pp.117-138, 2007.

G. A. Böhmig, H. Regele, M. Exner, V. Derhartunian, J. Kletzmayr et al., C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption, J Am Soc Nephrol JASN, vol.12, issue.11, pp.2482-2491, 2001.

G. Bartel, M. Wahrmann, H. Regele, Z. Kiki?, G. Fischer et al., Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.10, issue.9, pp.2033-2075, 2010.

M. D. Stegall, J. Gloor, J. L. Winters, S. B. Moore, and S. Degoey, A comparison of plasmapheresis versus high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.6, issue.2, pp.346-51, 2006.

A. Jawdeh, B. G. Cuffy, M. C. Alloway, R. R. Shields, A. R. Woodle et al., Desensitization in kidney transplantation: review and future perspectives, Clin Transplant, vol.28, issue.4, pp.494-507, 2014.

N. Maillard, L. Absi, G. Claisse, I. Masson, E. Alamartine et al., Protein A-Based Immunoadsorption Is More Efficient Than Conventional Plasma Exchange to Remove Circulating Anti-HLA Antibodies, Blood Purif, vol.40, issue.2, pp.167-72, 2015.

D. F. Pinelli, A. A. Zachary, J. J. Friedewald, D. W. Gjertson, M. A. Evans et al., Prognostic tools to assess candidacy for and efficacy of antibody-removal therapy, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, 2018.

J. Visentin, T. Bachelet, C. Borg, N. Franchini, T. Nong et al., Reassessment of T Lymphocytes Crossmatches Results Prediction With Luminex Class I Single Antigen Flow Beads Assay, Transplantation, vol.101, issue.3, pp.624-654, 2017.

E. Velidedeoglu, M. W. Cavaillé-coll, S. Bala, O. A. Belen, Y. Wang et al., Summary of 2017 FDA Public Workshop: Antibody-mediated Rejection in Kidney Transplantation, Transplantation, vol.102, issue.6, pp.257-64, 2018.

A. A. Zachary, R. A. Montgomery, and M. S. Leffell, Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin, Hum Immunol, vol.66, issue.4, pp.364-70, 2005.

T. Khuu, M. Cadeiras, N. Wisniewski, E. F. Reed, and M. C. Deng, Reduced HLA Class II antibody response to proteasome inhibition in heart transplantation, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, vol.34, issue.6, pp.863-868, 2015.

C. Yamada, D. S. Ramon, M. Cascalho, R. S. Sung, A. B. Leichtman et al., Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipients. Transfusion (Paris), vol.55, pp.727-762, 2015.

J. Cid, G. Carbassé, B. Andreu, A. Baltanás, A. Garcia-carulla et al., Efficacy and safety of plasma exchange: ann 11-year single-center experience of 2730 procedures in 317 patients, Transfus Apher Sci Off J World Apher Assoc Off J Eur Soc Haemapheresis, vol.51, issue.2, pp.209-223, 2014.

N. Braun and T. Bosch, Immunoadsorption, current status and future developments, Expert Opin Investig Drugs, vol.9, issue.9, pp.2017-2055, 2000.

C. Morath, J. Beimler, G. Opelz, S. Scherer, J. Schmidt et al., Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy, Transpl Int Off J Eur Soc Organ Transplant, vol.25, issue.5, pp.506-523, 2012.

. Ix--bibliographie,

J. Dausset,

, Acta Haematol, vol.20, issue.1-4, pp.156-66, 1958.

J. Klein and A. Sato, The HLA system. First of two parts, N Engl J Med, vol.343, issue.10, pp.702-711, 2000.

P. M. Porrett, Biologic mechanisms and clinical consequences of pregnancy alloimmunization, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.18, issue.5, pp.1059-67, 2018.

E. Masson, C. Vidal, M. Deschamps, S. Bongain, C. Thevenin et al., Incidence and risk factors of anti-HLA immunization after pregnancy, Hum Immunol, vol.74, issue.8, pp.946-51, 2013.

G. Hönger, I. Fornaro, C. Granado, J. Tiercy, I. Hösli et al., Frequency and determinants of pregnancy-induced child-specific sensitization, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.13, issue.3, pp.746-53, 2013.

C. A. Van-kampen, M. Versteeg-vd-voort-maarschalk, J. Langerak-langerak, D. L. Roelen, and F. Claas, Kinetics of the pregnancy-induced humoral and cellular immune response against the paternal HLA class I antigens of the child, Hum Immunol, vol.63, issue.6, pp.452-460, 2002.

D. J. Triulzi, S. Kleinman, R. M. Kakaiya, M. P. Busch, P. J. Norris et al., The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion (Paris), vol.49, pp.1825-1860, 2009.

J. P. Dutcher, C. A. Schiffer, J. Aisner, and P. H. Wiernik, Long-term follow-up patients with leukemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunized, Blood, vol.58, issue.5, pp.1007-1018, 1981.

G. Opelz, B. Graver, M. R. Mickey, and P. I. Terasaki, Lymphocytotoxic antibody responses to transfusions in potential kidney transplant recipients, Transplantation, vol.32, issue.3, pp.177-83, 1981.

E. T. Everett, K. J. Kao, and J. C. Scornik, Class I HLA molecules on human erythrocytes. Quantitation and transfusion effects, Transplantation, vol.44, issue.1, pp.123-132, 1987.

K. J. Kao, D. J. Cook, and J. C. Scornik, Quantitative analysis of platelet surface HLA by W6/32 anti-HLA monoclonal antibody, Blood, vol.68, issue.3, pp.627-659, 1986.

S. Dzik, J. Aubuchon, L. Jeffries, S. Kleinman, C. Manno et al., Leukocyte reduction of blood components: public policy and new technology, Transfus Med Rev, vol.14, issue.1, pp.34-52, 2000.

J. C. Scornik, W. W. Pfaff, R. J. Howard, R. S. Fennell, E. Ramos et al., Increased antibody responsiveness to blood transfusions in pediatric patients, Transplantation, vol.58, issue.12, pp.1361-1366, 1994.

M. Karpinski, D. Pochinco, I. Dembinski, W. Laidlaw, J. Zacharias et al., Leukocyte reduction of red blood cell transfusions does not decrease allosensitization rates in potential kidney transplant candidates, J Am Soc Nephrol JASN, vol.15, issue.3, pp.818-842, 2004.

R. M. Kakaiya, D. J. Triulzi, D. J. Wright, W. R. Steele, S. H. Kleinman et al., Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors. Transfusion (Paris), vol.50, pp.1328-1362, 2010.

E. G. Reisner, D. D. Kostyu, G. Phillips, C. Walker, and D. V. Dawson, Alloantibody responses in multiply transfused sickle cell patients, Tissue Antigens, vol.30, issue.4, pp.161-167, 1987.

C. Wiebe, I. W. Gibson, T. D. Blydt-hansen, M. Karpinski, J. Ho et al., Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.12, issue.5, pp.1157-67, 2012.

M. J. Everly, L. M. Rebellato, C. E. Haisch, M. Ozawa, K. Parker et al., Incidence and impact of de novo donor-specific alloantibody in primary renal allografts, Transplantation, vol.95, issue.3, pp.410-417, 2013.

J. D. Smith, N. R. Banner, I. M. Hamour, M. Ozawa, A. Goh et al., De novo donor HLAspecific antibodies after heart transplantation are an independent predictor of poor patient survival, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.11, issue.2, pp.312-321, 2011.

S. Safavi, D. R. Robinson, S. Soresi, M. Carby, and J. D. Smith, De novo donor HLA-specific antibodies predict development of bronchiolitis obliterans syndrome after lung transplantation, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, vol.33, issue.12, pp.1273-81, 2014.

M. R. Morrell, J. M. Pilewski, C. J. Gries, M. R. Pipeling, M. M. Crespo et al., De novo donorspecific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, vol.33, issue.12, pp.1288-94, 2014.

D. Bello, A. , C. , N. Muscari, F. Lavayssière et al., Prevalence, incidence and risk factors for donor-specific anti-HLA antibodies in maintenance liver transplant patients, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.14, issue.4, pp.867-75, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01915082

H. Kaneku, J. G. O'leary, N. Banuelos, L. W. Jennings, B. M. Susskind et al., De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.13, issue.6, pp.1541-1549, 2013.

J. Sellarés, D. G. De-freitas, M. Mengel, J. Reeve, G. Einecke et al., Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.12, issue.2, pp.388-99, 2012.

D. Bello, A. , C. , N. Sallusto, F. Guilbeau-frugier et al., Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomy, Clin J Am Soc Nephrol CJASN, vol.7, issue.8, pp.1310-1319, 2012.

J. J. Augustine, K. J. Woodside, A. Padiyar, E. Q. Sanchez, D. E. Hricik et al., Independent of nephrectomy, weaning immunosuppression leads to late sensitization after kidney transplant failure, Transplantation, vol.94, issue.7, pp.738-781, 2012.

C. Lefaucheur, A. Loupy, G. S. Hill, J. Andrade, D. Nochy et al., Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation, J Am Soc Nephrol JASN, vol.21, issue.8, pp.1398-406, 2010.

J. D. Smith, I. M. Hamour, N. R. Banner, and M. L. Rose, C4d fixing, luminex binding antibodies -a new tool for prediction of graft failure after heart transplantation, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.7, issue.12, pp.2809-2824, 2007.

R. Patel and P. I. Terasaki, Significance of the positive crossmatch test in kidney transplantation, N Engl J Med, vol.280, issue.14, pp.735-744, 1969.

L. C. Racusen, K. Solez, R. B. Colvin, S. M. Bonsib, M. C. Castro et al., The Banff 97 working classification of renal allograft pathology, Kidney Int, vol.55, issue.2, pp.713-736, 1999.

M. Haas, A. Loupy, C. Lefaucheur, C. Roufosse, D. Glotz et al., The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.18, issue.2, pp.293-307, 2018.

Q. Zhang and E. F. Reed, The importance of non-HLA antibodies in transplantation, Nat Rev Nephrol, vol.12, issue.8, pp.484-95, 2016.

M. Delville, B. Lamarthée, S. Pagie, S. B. See, M. Rabant et al., Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens, J Am Soc Nephrol JASN, 201908.

G. J. Berry, M. M. Burke, C. Andersen, P. Bruneval, M. Fedrigo et al., International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, vol.32, issue.12, pp.1147-62, 2013.

D. J. Levine, A. R. Glanville, C. Aboyoun, J. Belperio, C. Benden et al., Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, vol.35, issue.4, pp.397-406, 2016.

C. B. Drachenberg, J. R. Torrealba, B. J. Nankivell, E. B. Rangel, I. M. Bajema et al., Guidelines for the diagnosis of antibody-mediated rejection in pancreas allografts-updated Banff grading schema, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.11, issue.9, pp.1792-802, 2011.

A. J. Demetris, C. Bellamy, S. G. Hübscher, J. O'leary, P. S. Randhawa et al., , 2016.

, Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.16, issue.10, pp.2816-2851, 2016.

A. Loupy and C. Lefaucheur, Antibody-Mediated Rejection of Solid-Organ Allografts, N Engl J Med, vol.379, issue.12, pp.1150-60, 201820.

A. Loupy, C. Suberbielle-boissel, G. S. Hill, C. Lefaucheur, D. Anglicheau et al., Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donorspecific antibodies, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.9, issue.11, pp.2561-70, 2009.

A. Loupy, G. S. Hill, and S. C. Jordan, The impact of donor-specific anti-HLA antibodies on late kidney allograft failure, Nat Rev Nephrol, vol.8, issue.6, pp.348-57, 2012.

K. Murata and W. M. Baldwin, Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection, Transplant Rev Orlando Fla, vol.23, issue.3, pp.139-50, 2009.

E. A. Farkash and R. B. Colvin, Diagnostic challenges in chronic antibody-mediated rejection, Nat Rev Nephrol, vol.8, issue.5, pp.255-262, 2012.

T. Hirohashi, S. Uehara, C. M. Chase, P. Dellapelle, J. C. Madsen et al., Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.10, issue.3, pp.510-517, 2010.

P. F. Halloran, J. M. Venner, K. S. Madill-thomsen, G. Einecke, M. D. Parkes et al., Review: The transcripts associated with organ allograft rejection, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.18, issue.4, pp.785-95, 2018.

S. Yazdani, J. Callemeyn, S. Gazut, E. Lerut, H. De-loor et al., Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation, Kidney Int, vol.95, issue.1, pp.188-98, 2019.
URL : https://hal.archives-ouvertes.fr/hal-01964955

X. Zhang and E. F. Reed, Effect of antibodies on endothelium, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.9, issue.11, pp.2459-65, 2009.

N. El-awar, J. Lee, and P. I. Terasaki, HLA antibody identification with single antigen beads compared to conventional methods, Hum Immunol, vol.66, issue.9, pp.989-97, 2005.

M. Haarberg, K. Tambur, and A. , Detection of donor-specific antibodies in kidney transplantation, vol.110, 2014.

J. M. Gloor, J. L. Winters, L. D. Cornell, L. A. Fix, S. R. Degoey et al., Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.10, issue.3, pp.582-591, 2010.

D. Kannabhiran, J. Lee, J. E. Schwartz, R. Friedlander, M. Aull et al., Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure, Transplantation, vol.99, issue.6, pp.1156-64, 2015.

J. Visentin, T. Bachelet, C. Borg, N. Franchini, T. Nong et al., Reassessment of T Lymphocytes Crossmatches Results Prediction With Luminex Class I Single Antigen Flow Beads Assay, Transplantation, vol.101, issue.3, pp.624-654, 2017.

C. Wiebe, I. W. Gibson, T. D. Blydt-hansen, D. Pochinco, P. E. Birk et al., Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.15, issue.11, pp.2921-2951, 2015.

J. G. O'leary, H. Kaneku, B. M. Susskind, L. W. Jennings, M. A. Neri et al., High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.11, issue.9, pp.1868-76, 2011.

K. Mizutani, P. Terasaki, E. Hamdani, V. Esquenazi, A. Rosen et al., The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patients, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.7, issue.4, pp.1027-1058, 2007.

C. Lefaucheur, D. Nochy, J. Andrade, J. Verine, C. Gautreau et al., Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.9, issue.5, pp.1099-107, 2009.

J. Visentin, M. Vigata, S. Daburon, C. Contin-bordes, V. Fremeaux-bacchi et al., Deciphering complement interference in anti-human leukocyte antigen antibody detection with flow beads assays, Transplantation, vol.98, issue.6, pp.625-656, 2014.

G. Guidicelli, J. Visentin, N. Franchini, C. Borg, P. Merville et al., Prevalence, distribution and amplitude of the complement interference phenomenon in single antigen flow beads assays. HLA, vol.91, pp.507-520, 2018.

M. Schnaidt, C. Weinstock, M. Jurisic, B. Schmid-horch, E. A. Wernet et al., HLA antibody specification using single-antigen beads--a technical solution for the prozone effect, Transplantation, vol.92, issue.5, pp.510-515, 2011.

E. K. Jacob, D. Goey, S. R. Gandhi, and M. J. , Positive virtual crossmatch with negative flow crossmatch results in two cases, Transpl Immunol, vol.25, issue.1, pp.77-81, 2011.

J. Visentin, M. Marroc, G. Guidicelli, T. Bachelet, T. Nong et al., Clinical impact of preformed donor-specific denatured class I HLA antibodies after kidney transplantation, Clin Transplant, vol.29, issue.5, pp.393-402, 2015.

J. Visentin, G. Guidicelli, J. Moreau, J. Lee, and J. Taupin, Deciphering allogeneic antibody response against native and denatured HLA epitopes in organ transplantation, Eur J Immunol, vol.45, issue.7, pp.2111-2132, 2015.

J. Visentin, L. Minder, J. Lee, J. Taupin, D. Primo et al., Calibration free concentration analysis by surface plasmon resonance in a capture mode, Talanta, vol.148, pp.478-85, 2016.

J. Visentin, L. Couzi, C. Dromer, M. Neau-cransac, G. Guidicelli et al., Overcoming nonspecific binding to measure the active concentration and kinetics of serum anti-HLA antibodies by surface plasmon resonance, Biosens Bioelectron, vol.117, pp.191-200, 2018.

J. Visentin, D. L. Leu, A. Mulder, F. Jambon, L. Badier et al., Measuring anti-HLA antibody active concentration and affinity by surface plasmon resonance: Comparison with the luminex single antigen flow beads and T-cell flow cytometry crossmatch results, Mol Immunol, vol.108, pp.34-44, 2019.

A. Loupy, C. Lefaucheur, D. Vernerey, C. Prugger, J. Duong-van-huyen et al., Complement-binding anti-HLA antibodies and kidney-allograft survival, N Engl J Med, vol.369, issue.13, pp.1215-1241, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02325503

M. Wahrmann, G. Bartel, M. Exner, H. Regele, G. F. Körmöczi et al., Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients, Transpl Int Off J Eur Soc Organ Transplant, vol.22, issue.10, pp.982-991, 2009.

A. Sicard, S. Ducreux, M. Rabeyrin, L. Couzi, B. Mcgregor et al., Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss, J Am Soc Nephrol JASN, vol.26, issue.2, pp.457-67, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01910934

M. Yell, B. L. Muth, D. B. Kaufman, A. Djamali, and T. M. Ellis, C1q Binding Activity of De Novo Donorspecific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection, Transplantation, vol.99, issue.6, pp.1151-1156, 2015.

J. H. Lan and K. Tinckam, Clinical Utility of Complement Dependent Assays in Kidney Transplantation, Transplantation, vol.102, issue.1S, pp.14-22, 2018.

H. C. Sullivan, H. M. Gebel, and R. A. Bray, Understanding solid-phase HLA antibody assays and the value of MFI, Hum Immunol, vol.78, issue.7-8, pp.471-80, 2017.

J. G. O'leary, H. Kaneku, N. Banuelos, L. W. Jennings, G. B. Klintmalm et al., Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.15, issue.4, pp.1003-1016, 2015.

C. Lefaucheur, D. Viglietti, C. Bentlejewski, J. Duong-van-huyen, D. Vernerey et al., IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury, J Am Soc Nephrol JASN, vol.27, issue.1, pp.293-304, 2016.

R. Mccalmon, G. Tardif, M. Sheehan, K. Fitting, W. Kortz et al., IgM antibodies in renal transplantation, Clin Transplant, vol.11, issue.6, pp.558-64, 1997.

C. F. Bryan, J. Martinez, N. Muruve, P. W. Nelson, G. E. Pierce et al., IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotype, Clin Transplant, vol.15, issue.6, pp.28-35, 2001.

R. H. Kerman, B. Susskind, I. Buyse, P. Pryzbylowski, J. Ruth et al., Flow cytometrydetected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome, Transplantation, vol.68, issue.12, pp.1855-1863, 1999.

P. Stastny, S. Ring, C. Lu, J. Arenas, M. Han et al., Role of immunoglobulin (Ig)-G and IgM antibodies against donor human leukocyte antigens in organ transplant recipients, Hum Immunol, vol.70, issue.8, pp.600-604, 2009.

A. Babu, A. Andreou, D. Briggs, N. Krishnan, R. Higgins et al., Clinical Relevance of Donor-Specific IgM Antibodies in HLA Incompatible Renal Transplantation: A Retrospective Single-Center Study, Clin Transpl, vol.32, pp.173-182, 2016.

P. Koka, D. Chia, P. I. Terasaki, H. Chan, J. Chia et al., The role of IgA anti-HLA class I antibodies in kidney transplant survival, Transplantation, vol.56, issue.1, pp.207-218, 1993.

R. H. Kerman, B. Susskind, R. Buelow, J. Regan, P. Pouletty et al., Correlation of ELISAdetected IgG and IgA anti-HLA antibodies in pretransplant sera with renal allograft rejection, Transplantation, vol.62, issue.2, pp.201-206, 1996.

M. Arnold, C. Bach, F. M. Heinemann, P. A. Horn, M. Ziemann et al., Anti-HLA alloantibodies of the IgA isotype in re-transplant candidates part II: Correlation with graft survival, Int J Immunogenet, vol.45, issue.3, pp.95-101, 2018.

P. Archdeacon, M. Chan, C. Neuland, E. Velidedeoglu, J. Meyer et al., Summary of FDA antibody-mediated rejection workshop, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.11, issue.5, pp.896-906, 2011.

S. S. Wan, T. D. Ying, K. Wyburn, D. M. Roberts, M. Wyld et al., The Treatment of Antibody-Mediated Rejection in Kidney Transplantation: An Updated Systematic Review and Meta-Analysis, Transplantation, vol.102, issue.4, pp.557-68, 2018.

G. A. Böhmig, M. Wahrmann, H. Regele, M. Exner, B. Robl et al., Immunoadsorption in severe C4d-positive acute kidney allograft rejection: a randomized controlled trial, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.7, issue.1, pp.117-138, 2007.

G. A. Böhmig, H. Regele, M. Exner, V. Derhartunian, J. Kletzmayr et al., C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption, J Am Soc Nephrol JASN, vol.12, issue.11, pp.2482-2491, 2001.

D. Viglietti, A. Loupy, A. O. Bestard, O. Van-huyen, J. Taupin et al., Dynamic Prognostic Score to Predict Kidney Allograft Survival in Patients with Antibody-Mediated Rejection, J Am Soc Nephrol JASN, vol.29, issue.2, pp.606-625, 2018.

M. J. Everly, J. J. Everly, L. J. Arend, P. Brailey, B. Susskind et al., Reducing de novo donorspecific antibody levels during acute rejection diminishes renal allograft loss, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.9, issue.5, pp.1063-71, 2009.

D. Viglietti, Y. Bouatou, V. D. Kheav, A. O. Suberbielle-boissel, C. Glotz et al., Complementbinding anti-HLA antibodies are independent predictors of response to treatment in kidney recipients with antibody-mediated rejection, Kidney Int, vol.94, issue.4, pp.773-87, 2018.

S. Sethi, J. Choi, M. Toyoda, A. Vo, A. Peng et al., Desensitization: Overcoming the Immunologic Barriers to Transplantation, J Immunol Res, p.6804678, 2017.

A. Jawdeh, B. G. Cuffy, M. C. Alloway, R. R. Shields, A. R. Woodle et al., Desensitization in kidney transplantation: review and future perspectives, Clin Transplant, vol.28, issue.4, pp.494-507, 2014.

G. Bartel, M. Wahrmann, H. Regele, Z. Kiki?, G. Fischer et al., Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.10, issue.9, pp.2033-2075, 2010.

L. Rostaing, N. Congy, A. Aarnink, S. Maggioni, A. Allal et al., Efficacy of immunoadsorption to reduce donor-specific alloantibodies in kidney-transplant candidates, Exp Clin Transplant Off J Middle East Soc Organ Transplant, vol.13, issue.1, pp.201-207, 2015.

C. Morath, J. Beimler, G. Opelz, S. Scherer, J. Schmidt et al., Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy, Transpl Int Off J Eur Soc Organ Transplant, vol.25, issue.5, pp.506-523, 2012.

B. J. Orandi, J. M. Garonzik-wang, A. B. Massie, A. A. Zachary, J. R. Montgomery et al., Quantifying the risk of incompatible kidney transplantation: a multicenter study, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.14, issue.7, pp.1573-80, 2014.

R. Higgins, D. Lowe, M. Hathaway, C. Williams, F. T. Lam et al., Human leukocyte antigen antibody-incompatible renal transplantation: excellent medium-term outcomes with negative cytotoxic crossmatch, Transplantation, vol.92, issue.8, pp.900-906, 2011.

M. A. Mujtaba, W. Goggins, A. Lobashevsky, A. A. Sharfuddin, M. S. Yaqub et al., The strength of donor-specific antibody is a more reliable predictor of antibody-mediated rejection than flow cytometry crossmatch analysis in desensitized kidney recipients, Clin Transplant, vol.25, issue.1, pp.96-102, 2011.

A. A. Vo, A. Sinha, M. Haas, J. Choi, J. Mirocha et al., Factors Predicting Risk for Antibodymediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization, Transplantation, vol.99, issue.7, pp.1423-1453, 2015.

G. Tydén, G. Kumlien, and M. Efvergren, Present techniques for antibody removal. Transplantation, vol.84, pp.27-29, 2007.

D. M. Ward, Conventional apheresis therapies: a review, J Clin Apheresis, vol.26, issue.5, pp.230-238, 2011.

A. A. Kaplan, Therapeutic plasma exchange: a technical and operational review, J Clin Apheresis, vol.28, issue.1, pp.3-10, 2013.

H. M. Reeves and J. L. Winters, The mechanisms of action of plasma exchange, Br J Haematol, vol.164, issue.3, pp.342-51, 2014.

G. A. Rock, K. H. Shumak, N. A. Buskard, V. S. Blanchette, J. G. Kelton et al., Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group, N Engl J Med, vol.325, issue.6, pp.393-400, 1991.

J. Schwartz, A. Padmanabhan, N. Aqui, R. A. Balogun, L. Connelly-smith et al., Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue, J Clin Apheresis, vol.31, issue.3, pp.149-62, 2016.

N. Braun and T. Bosch, Immunoadsorption, current status and future developments, Expert Opin Investig Drugs, vol.9, issue.9, pp.2017-2055, 2000.

N. Braun and T. Risler, Immunoadsorption as a tool for the immunomodulation of the humoral and cellular immune system in autoimmune disease, Ther Apher Off J Int Soc Apher Jpn Soc Apher, vol.3, issue.3, pp.240-245, 1999.

W. Rönspeck, R. Brinckmann, R. Egner, F. Gebauer, D. Winkler et al., Peptide based adsorbers for therapeutic immunoadsorption, Ther Apher Dial Off Peer-Rev J Int Soc Apher Jpn Soc Apher Jpn Soc Dial Ther, vol.7, issue.1, pp.91-98, 2003.

M. E. Williams and R. A. Balogun, Principles of separation: indications and therapeutic targets for plasma exchange, Clin J Am Soc Nephrol CJASN, vol.9, issue.1, pp.181-90, 2014.

A. Nicuolo, . Di, N. Braun, and T. Risler, Technical basis for immunoadsorption, EDTNA-ERCA J, vol.26, issue.3, pp.20-26, 2000.

P. Gjörstrup and R. M. Watt, Therapeutic protein A immunoadsorption. A review, Transfus Sci, vol.11, issue.3, pp.281-302, 1990.

A. A. Kaplan and S. E. Halley, Plasma exchange with a rotating filter, Kidney Int, vol.38, issue.1, pp.160-166, 1990.

M. Belàk, H. Borberg, C. Jimenez, and K. Oette, Technical and clinical experience with protein A immunoadsorption columns, Transfus Sci, vol.15, issue.4, pp.419-441, 1994.

P. Biesenbach, S. Schmaldienst, J. S. Smolen, W. H. Hörl, K. Derfler et al., Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity. Atheroscler Suppl, vol.10, pp.114-135, 2009.

A. A. Kaplan, A simple and accurate method for prescribing plasma exchange, ASAIO Trans, vol.36, issue.3, pp.597-599, 1990.

R. M. Hakim, E. Milford, J. Himmelfarb, R. Wingard, J. M. Lazarus et al., Extracorporeal removal of anti-HLA antibodies in transplant candidates, Am J Kidney Dis Off J Natl Kidney Found, vol.16, issue.5, pp.423-454, 1990.

N. Maillard, L. Absi, G. Claisse, I. Masson, E. Alamartine et al., Protein A-Based Immunoadsorption Is More Efficient Than Conventional Plasma Exchange to Remove Circulating Anti-HLA Antibodies, Blood Purif, vol.40, issue.2, pp.167-72, 2015.

E. Velidedeoglu, M. W. Cavaillé-coll, S. Bala, O. A. Belen, Y. Wang et al., Summary of 2017 FDA Public Workshop: Antibody-mediated Rejection in Kidney Transplantation, Transplantation, vol.102, issue.6, pp.257-64, 2018.

T. Khuu, M. Cadeiras, N. Wisniewski, E. F. Reed, and M. C. Deng, Reduced HLA Class II antibody response to proteasome inhibition in heart transplantation, J Heart Lung Transplant Off Publ Int Soc Heart Transplant, vol.34, issue.6, pp.863-868, 2015.

C. Yamada, D. S. Ramon, M. Cascalho, R. S. Sung, A. B. Leichtman et al., Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipients. Transfusion (Paris), vol.55, pp.727-762, 2015.

A. A. Zachary, R. A. Montgomery, and M. S. Leffell, Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin, Hum Immunol, vol.66, issue.4, pp.364-70, 2005.

D. F. Pinelli, A. A. Zachary, J. J. Friedewald, D. W. Gjertson, M. A. Evans et al., Prognostic tools to assess candidacy for and efficacy of antibody-removal therapy, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, 2018.

D. Shemin, D. Briggs, and M. Greenan, Complications of therapeutic plasma exchange: a prospective study of 1,727 procedures, J Clin Apheresis, vol.22, issue.5, pp.270-276, 2007.

J. Cid, G. Carbassé, B. Andreu, A. Baltanás, A. Garcia-carulla et al., Efficacy and safety of plasma exchange: ann 11-year single-center experience of 2730 procedures in 317 patients, Transfus Apher Sci Off J World Apher Assoc Off J Eur Soc Haemapheresis, vol.51, issue.2, pp.209-223, 2014.

A. Kaplan, Complications of apheresis, Semin Dial, vol.25, issue.2, pp.152-160, 2012.